These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23651789)

  • 1. Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study.
    Wally V; Kitzmueller S; Lagler F; Moder A; Hitzl W; Wolkersdorfer M; Hofbauer P; Felder TK; Dornauer M; Diem A; Eiler N; Bauer JW
    Orphanet J Rare Dis; 2013 May; 8():69. PubMed ID: 23651789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
    Wally V; Hovnanian A; Ly J; Buckova H; Brunner V; Lettner T; Ablinger M; Felder TK; Hofbauer P; Wolkersdorfer M; Lagler FB; Hitzl W; Laimer M; Kitzmüller S; Diem A; Bauer JW
    J Am Acad Dermatol; 2018 May; 78(5):892-901.e7. PubMed ID: 29410318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review.
    Limmer AL; Nwannunu CE; Shah R; Coleman K; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 May; 24(3):7-9. PubMed ID: 31095348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.
    Ablinger M; Felder TK; Wimmer M; Zauner R; Hofbauer P; Lettner T; Wolkersdorfer M; Lagler FB; Diem A; Bauer JW; Wally V
    Orphanet J Rare Dis; 2018 Nov; 13(1):193. PubMed ID: 30382914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermolysis bullosa simplex Dowling-Meara].
    Frangu M; Gedde-Dahl T; Verder H
    Ugeskr Laeger; 2006 Nov; 168(48):4222-4. PubMed ID: 17147951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive acantholysis as the major histological feature of a severe case of Dowling Meara-epidermolysis bullosa simplex: a reappraisal of acantholysis in the newborn.
    Darwich E; Vicente A; Bolling MC; González-Enseñat MA; Cusi V; Fortuny C; Bombí JA; Jonkman MF; Mascaró JM
    Eur J Dermatol; 2011; 21(6):966-71. PubMed ID: 21856558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel keratin 14 gene mutations in patients from Hungary with epidermolysis bullosa simplex.
    Csikós M; Szalai Z; Becker K; Sebõk B; Schneider I; Horváth A; Kárpáti S
    Exp Dermatol; 2004 Mar; 13(3):185-91. PubMed ID: 14987259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations.
    Rugg EL; Horn HM; Smith FJ; Wilson NJ; Hill AJ; Magee GJ; Shemanko CS; Baty DU; Tidman MJ; Lane EB
    J Invest Dermatol; 2007 Mar; 127(3):574-80. PubMed ID: 17039244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex.
    Lee GH; Lekwuttikarn R; Tafoya E; Martin M; Sarin KY; Teng JM
    J Invest Dermatol; 2022 Feb; 142(2):382-389. PubMed ID: 34536484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa simplex Dowling-Meara: troublesome blistering and pruritus in an adult patient.
    McGrath JA; Burrows NP; Russell Jones R; Eady RA
    Dermatology; 1993; 186(1):68-71. PubMed ID: 8435522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment.
    Castela E; Tulic MK; Rozières A; Bourrat E; Nicolas JF; Kanitakis J; Vabres P; Bessis D; Mazereeuw J; Morice-Picard F; Baty D; Berard F; Lacour JP; Passeron T; Chiaverini C
    Br J Dermatol; 2019 Feb; 180(2):357-364. PubMed ID: 29932457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure.
    Jerábková B; Marek J; Bucková H; Kopecková L; Veselý K; Valícková J; Fajkus J; Fajkusová L
    Br J Dermatol; 2010 May; 162(5):1004-13. PubMed ID: 20030639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical spectrum of epidermolysis bullosa simplex.
    Horn HM; Tidman MJ
    Br J Dermatol; 2000 Mar; 142(3):468-72. PubMed ID: 10735952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype.
    Arin MJ; Grimberg G; Schumann H; De Almeida H; Chang YR; Tadini G; Kohlhase J; Krieg T; Bruckner-Tuderman L; Has C
    Br J Dermatol; 2010 Jun; 162(6):1365-9. PubMed ID: 20199538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy.
    Cao T; Longley MA; Wang XJ; Roop DR
    J Cell Biol; 2001 Feb; 152(3):651-6. PubMed ID: 11157990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex.
    García M; Santiago JL; Terrón A; Hernández-Martín A; Vicente A; Fortuny C; De Lucas R; López JC; Cuadrado-Corrales N; Holguín A; Illera N; Duarte B; Sánchez-Jimeno C; Llames S; García E; Ayuso C; Martínez-Santamaría L; Castiglia D; De Luca N; Torrelo A; Mechan D; Baty D; Zambruno G; Escámez MJ; Del Río M
    Br J Dermatol; 2011 Sep; 165(3):683-92. PubMed ID: 21623745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the helix termination peptide of keratin 5 causing epidermolysis bullosa simplex Dowling-Meara.
    Irvine AD; McKenna KE; Bingham A; Nevin NC; Hughes AE
    J Invest Dermatol; 1997 Dec; 109(6):815-6. PubMed ID: 9406827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recurrent keratin 14 mutation in Dowling-Meara epidermolysis bullosa simplex in a Chinese family.
    Wu JW; Xiao SX
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):484-6. PubMed ID: 18717745
    [No Abstract]   [Full Text] [Related]  

  • 19. Aluminum chloride hexahydrate and blistering in epidermolysis bullosa simplex.
    Younger IR; Priestley GC; Tidman MJ
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):930-1. PubMed ID: 2254479
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidermolysis bullosa nevus arising in a patient with Dowling-Meara type epidermolysis bullosa simplex with a novel K5 mutation.
    Sugiyama-Fukamatsu H; Suzuki N; Nakanishi G; Iwatsuki K
    J Dermatol; 2009 Aug; 36(8):447-52. PubMed ID: 19691749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.